Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine TAP block for postoperative analgesia after laparoscopic colorectal cancer surgery
ChiCTR2500101706Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in colorectal cancer (CRC) and postoperative pain comparing Ropivacaine TAP block with Liposomal bupivacaine TAP block (2 arms). Primary endpoint: Postoperative pain score. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
bupivacaineropivacaine
03
Conditions
colorectal cancer (CRC)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500101706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101706.